DANBURY, Conn. and WESTLAKE VILLAGE, Calif. — November 11, 2025 — Leads & Copy — MannKind Corporation (Nasdaq: MNKD) today announced that Chief Executive Officer Michael Castagna and Chief Financial Officer Chris Prentiss are scheduled to present and share updates during the Jefferies London Healthcare Conference on Wednesday, November 19, at 6:30 am ET/11:30 am GMT.
The live audio webcast of the session will be available on MannKind Corporation’s website. Recorded versions will also be available on the website for approximately 90 days following the conference.
MannKind Corporation is a biopharmaceutical company dedicated to transforming chronic disease care through patient-centric solutions. The company develops and commercializes treatments that address unmet medical needs, including diabetes, pulmonary hypertension, and fluid overload in heart failure and chronic kidney disease, with a focus on cardiometabolic and orphan lung diseases.
MannKind aims to deliver therapies designed to fit seamlessly into daily life, with expertise in drug-device combinations.
Investor Relations Contact: Ana Kapor, Email: ir@mnkd.com. Media Relations Contact: Christie Iacangelo, Email: media@mnkd.com
Source: MannKind
